期刊文献+

CD4^(+)T细胞诱导性缺失小鼠模型构建

Generation of a mouse model for inducible depletion of CD4^(+)T cells
下载PDF
导出
摘要 目的构建白喉毒素诱导的CD4^(+)T细胞特异性缺失小鼠(Cd4-DTR)模型。方法利用CRISPR/Cas9技术,通过同源重组的方式,在C57BL/6小鼠Cd4基因终止密码子位点定点插入IRES-DTR表达元件。流式细胞术检测未经处理的Cd4-DTR小鼠脾和硬脑膜CD4^(+)T细胞数量及比例与野生小鼠有无差异,单次注射不同剂量白喉毒素后CD4^(+)T细胞的减少程度以及CD4^(+)T细胞缺失的持续时间。结果鼠尾PCR鉴定证明Cd4-DTR模型构建成功,未经处理的Cd4-DTR小鼠脾中的CD4^(+)T细胞数量及比例低于野生小鼠,但硬脑膜中没有差异。单次注射75 mg/kg白喉毒素后Cd4-DTR小鼠的脾和硬脑膜中的CD4^(+)T细胞数量及比例都大幅度下降且都有显著性差异(P<0.01),单次白喉毒素注射后脾脏中的CD4^(+)T细胞缺失持续时间超过1周。利用3%DSS诱导小鼠急性结肠炎,结果显示Cd4-DTR小鼠肠道的病理改变弱于对照小鼠。结论成功构建Cd4-DTR小鼠模型,为CD4^(+)T细胞功能研究提供了新的小鼠模型。缺失CD4^(+)T细胞可能减轻DSS诱导的小鼠急性结肠炎。 This study aimed to establish a mouse model with diphtheria toxin-induced depletion of CD4^(+)T cells(referred to as Cd4-DTR mouse)by CRISPR/Cas9 technology,that is,IRES-DTR segment was inserted at the stop codon of Cd4 gene by homologous recombination.The proportion and number of CD4^(+)T cells in the spleen and cranial dura were detected by flow cytometry.Data showed that the number and proportion of CD4^(+)T cells in the spleen and cranial dura decreased significantly after Cd4-DTR mice were injected with 75 mg/kg diphtheria toxin.In the spleen,CD4^(+)T cell ablation could last more than 1 week after a single diphtheria toxin injection.And we found that the colon pathological changes were milder in Cd4-DTR mice with acute colitis induced by 3%DSS.So,deletion of T cells may have a protective effect on DSS-induced acute colitis.Therefore,Cd4-DTR murine model has been constructed successfully,which provides a new mouse model for the study of CD4^(+)T cell function.
作者 蒋慧 吴孟瑶 邹滔 董洁 张纪岩 袁增强 JIANG Hui;WU Mengyao;ZOU Tao;DONG Jie;ZHANG Jiyan;YUAN Zengqiang(Hengyang Medical School,University of South China,Hengyang 421001,China;Institute of Military Cognition and Brain Science,Academy of Military Medical Sciences,Beijing 100850,China)
出处 《免疫学杂志》 CAS CSCD 北大核心 2023年第5期435-440,共6页 Immunological Journal
关键词 Cd4-DTR CRISPR/Cas9 CD4^(+)T细胞 Cd4-DTR CRISPR/Cas9 CD4^(+)T cells
  • 相关文献

参考文献1

二级参考文献17

  • 1林剑萍,王华,王玲,卫红飞,胡晓平,王丽颖,于永利.HIV-1Tat基因的融合构建及在大肠杆菌中的高效表达[J].细胞与分子免疫学杂志,2005,21(1):33-36. 被引量:6
  • 2Kreitman RJ.Recombinant iamunotoxins for the treatment of haematological malignancies[J].Expert Opin Biol Ther,2004,4(7):1115-1128.
  • 3Martin PJ,Pei J,Gooley T.Evaluation of a CD25-specific immunotoxin for prevention of graft boil blood marrow transplant[J].Curr Opin Mol Ther,2004,10(8):552-560.
  • 4Kreitnan RJ.Recombinant toxins for the treatment of cancer[J].Curr Opin Mol Ther,2003,5 (1):44-51.
  • 5Foss FM,Saleh MN,Krueger JG,et al.Diphtheria toxin frsion proteins[J].Curr Top Microbiol Immunol,1998,234:63-81.
  • 6Klasse PJ,Mettem,Rosenkildens.CD4-chemokine receptor hybrids in human immunodeficiency virus type Ⅰ infection[J].J Virol,1999,73(9):7453-7466.
  • 7黄培堂,译.分子克隆实验指南[M].3版.北京:科学出版社,2002:127-30,627-628.
  • 8Mahalingam B,Boross P,Wang YF,et al.Combining mutations in HIV-1 protease to understand mechanisms of resistance[J].J Proteins,2002,48 (1):107-116.
  • 9Piascik P.FDA approves fusion protein for treatment of lymphoma[J].J Am Pharm Assoc (Wash),1999,39(4):571 -572.
  • 10Frankel AE,Powell BL,Hall PD,et al.Phase Ⅰ trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia[J].Clin Cancer Res,2002,8(5):1004-1013.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部